VaxInnate Raises $30 Million

VaxInnate Corp., a Cranbury, N.J.-based developer of vaccines for both pandemic and seasonal influenza, has raised $30 million in Series D funding. The Wellcome Trust led the round, and was joined by return backers New Leaf Venture Partners, Canaan Partners, HealthCare Ventures, Oxford Bioscience Partners, MedImmune Ventures and CHL Medical Ventures. The company has now raised more than $90 million in total VC funding.

North AmericaUSBriefs